OGT-TFF2轴介导肝内细胞间通讯与MASH发病机制
该研究在人和小鼠肝脏中分析OGT与TFF2表达,并在3D小鼠肝球体和GAN饮食喂养小鼠中评估TFF2的旁分泌作用及GalNAc修饰siRNA的干预效果。结果显示MASLD中OGT表达下降通过FOXA2促进TFF2转录和分泌,TFF2经CXCR4-STAT1/3信号增强CD4+ T细胞增殖与Th1/Th17分化,与CXCL12协同放大炎症;肝细胞特异性Tff2抑制可改善MASH进展而不影响单纯性脂肪变。
要点
- MASLD中肝细胞OGT表达下降通过FOXA2上调TFF2转录与分泌。
- TFF2经CXCR4-STAT1/3信号促进CD4+ T细胞增殖及Th1/Th17分化,与CXCL12协同放大炎症。
- 肝细胞特异性Tff2抑制可改善饮食诱导小鼠MASH进展而不影响单纯性脂肪变。
核心结论
- OGT-TFF2轴介导MASH发病过程中肝细胞与CD4 T细胞间的通讯,是慢性肝病的潜在治疗靶点。
研究设计与样本
- 研究在人和小鼠肝脏中分析OGT与TFF2表达,并在3D小鼠肝球体MASH模型及GAN饮食喂养小鼠中评估旁分泌因子作用与GalNAc修饰siRNA的干预效果。
主要发现
- MASLD中OGT表达下降通过FOXA2调控促进TFF2转录和分泌。
- 在3D小鼠肝球体中,TFF2加重MASH相关病理。
- TFF2经CXCR4-STAT1/3信号增强肝内CD4+ T细胞增殖及Th1/Th17分化,并与CXCL12协同放大炎症。
- 在饮食诱导小鼠模型中,肝细胞特异性Tff2抑制改善MASH进展而不影响单纯性脂肪变的发生。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Metabolic dysfunction-associated fatty liver disease (MASLD) encompasses a spectrum of liver pathologies ranging from simple steatosis to metabolic dysfunction-associated steatohepatitis (MASH) with fibrosis. The mechanisms governing disease progression, particularly the communication between hepatocytes and non-parenchymal cells, remain poorly understood. In this study, we demonstrate a novel paracrine factor through which O‑GlcNAc transferase (OGT) regulates intercellular crosstalk between hepatocytes and immune cells in MASH development. APPROACH AND RESULTS: OGT and trefoil factor 2 (TFF2) expression were analyzed in human and mouse livers. The effects of the paracrine factor on inflammation and fibrogenesis were further evaluated in a 3D mouse liver spheroid model of MASH. The GalNAc-modified siRNA targeting the paracrine factor was applied in Gubra-Amylin NASH (GAN) diet-fed mice to determine its therapeutic potential in preventing the MASH progression. Decreased OGT expression during MASLD promotes TFF2 transcription and secretion via forkhead box protein A2 (FOXA2) modulation. In 3D mouse liver spheroids, TFF2 exacerbates MASH-related pathologies. Mechanistically, TFF2 enhances hepatic CD4+ T cell proliferation and Th1/Th17 differentiation through CXC motif chemokine receptor 4 (CXCR4)-signal transducer and activator of transcription 1/3 (STAT1/3) signaling, cooperating with CXC motif chemokine ligand 12 (CXCL12) to amplify inflammation. Hepatocyte-specific Tff2 inhibition using GalNAc-modified siRNA in a diet-induced mouse model ameliorates MASH progression without affecting simple steatosis development. CONCLUSIONS: These results identify an OGT-TFF2 axis that mediates the crosstalk between hepatocytes and CD4 T cells during MASH pathogenesis, revealing a potential therapeutic target for the treatment of chronic liver disease.
引用
- Zhang L, Han C, Shrestha MM, et al. The OGT-TFF2 axis mediates intrahepatic crosstalk and MASH pathogenesis. Hepatology. 2025. PMID: 40587778. doi:10.1097/HEP.0000000000001445
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。